Approval · Notice of Compliance 22241 · 2019
VIMIZIM: Notice of Compliance 22241
Issued June 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22241
- Date
- June 5, 2019
- Company
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIMIZIM | Not yet assigned | — |
Medicinal ingredients
- ELOSULFASE ALFA 1 MG per ML